Ledger.Open graph →
SEC Form D · filed February 9, 2018

Cellect Biotechnology Ltd

Offering
$4.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KFAR SABA, L3
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Yuval N. Berman · Kfar Saba, L3DirectorEyal N. Leibovitz · Kfar Saba, L3ExecMichael N. Berelowitz · Kfar Saba, L3DirectorAbraham N. Nahmias · Kfar Saba, L3DirectorShai N. Yarkoni · Kfar Saba, L3Exec · DirectorRuth N. Ben Yakar · Kfar Saba, L3DirectorKasbian N. Chirich · Kfar Saba, L3DirectorTudor G. Uhlhorn · Harlingen, TXDirectorMichael F. Scaief · Harlingen, TXExecSamuel Weatherford · Tampa, FLDirectorWilliam Weatherford · Tampa, FLDirectorRaz Winiarsky · Hackensack, NJDirectorAndrew Weatherford · Tampa, FLExec · DirectorRobert R. Farris · Harlingen, TXDirectorDavid N. Braun · Kfar Saba, L3DirectorRuhama N. Avraham · Kfar Saba, L3DirectorDilip Badlani · New York, NYDirectorDavid M. Jones · VANCOUVER, British Columbia, CanadaExecDusan Berka · VANCOUVER, British Columbia, CanadaDirectorZahara M. Kanji · VANCOUVER, British Columbia, CanadaDirectorAnne Kreider · Greenwood Village, COExec · DirectorKeith L. Day · St. James, C8DirectorEdward A. Stevenson · Las Vegas, NVDirectorDavid N. Braun · Kfar Saba, L3DirectorRuhama N. Avraham · Kfar Saba, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗